Apr 22, 2024 | Cancer, Research
A groundbreaking combination therapy involving adagrasib (Krazati) alongside cetuximab (Erbitux) has demonstrated substantial efficacy and tolerability in individuals with advanced or metastatic colorectal cancer (mCRC) carrying KRAS G12C mutations. These encouraging...
Apr 21, 2024 | Research, Cancer
In recent years, the utilization of whole-genome sequencing (WGS) in precision oncology has experienced a notable upsurge. Initially established for rare and pediatric diseases, WGS has now gained traction in clinical labs for cancer diagnostics. Advantages of...